Biocomplex Katarsis has a pronounced hepato- and myelogenous protective effect. It is used in cases of hepatitis, in the complex prevention and correction of hematopoietic disorders, while having basic cancer radiation and cytostatic therapy. It is also effective against diseases accompanied by degenerative processes. It is effective as a preventive product that supports regeneration processes. In gerontological practice it is shown as a product that contributes to the active longevity extension.
Katarsis could be used in cases below:
- prevention of aging;
- active longevity extension;
- irradiation and treatment with cytotoxic drugs (chemotherapy);
- auxiliary correction and rehabilitation in cases of cancer;
- prevention and correction of viral infections including hepatitis;
- gastric and duodenum ulcer ancillary correction;
- recovery after infectious diseases.
Why is it innovative?
The innovative technology AXIS® – technology of biological material immobilization was used in production of Katarsis.
Thanks to AXIS (electron ray technology) every ingredient increases its efficiency and bioavailability (ability of its active substance to penetrate into the organism.).
Country of Origin: Russia